Guardian Asset Advisors LLC Sells 157 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Guardian Asset Advisors LLC lessened its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 4.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,514 shares of the company’s stock after selling 157 shares during the period. Guardian Asset Advisors LLC’s holdings in iShares U.S. Pharmaceuticals ETF were worth $231,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the stock. Allworth Financial LP grew its position in shares of iShares U.S. Pharmaceuticals ETF by 9.4% during the 3rd quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after buying an additional 159 shares during the period. Assetmark Inc. boosted its position in shares of iShares U.S. Pharmaceuticals ETF by 100.0% in the 3rd quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after purchasing an additional 216 shares during the last quarter. US Bancorp DE lifted its stake in iShares U.S. Pharmaceuticals ETF by 137.0% in the third quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after buying an additional 222 shares during the period. Janney Montgomery Scott LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 4.1% in the fourth quarter. Janney Montgomery Scott LLC now owns 6,699 shares of the company’s stock valued at $440,000 after buying an additional 261 shares during the period. Finally, Wealth Enhancement Advisory Services LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 11.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock worth $253,000 after buying an additional 356 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of IHE stock opened at $70.90 on Friday. The stock has a market cap of $716.09 million, a PE ratio of 6.49 and a beta of 0.58. The stock has a 50-day moving average of $67.43 and a 200-day moving average of $69.14. iShares U.S. Pharmaceuticals ETF has a one year low of $62.67 and a one year high of $72.94.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.